Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Channel Therapeutics Corp (CHRO)

Channel Therapeutics Corp (CHRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Channel Therapeutics Corp 4400 Route 9 South Suite 1000 Freehold NJ 07728 USA

www.chromocell.com Employees: 4 P: 877-265-8266

Description:

Chromocell Therapeutics Corporation is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive, therapeutics to alleviate pain and other associated medical conditions. Chromocell Therapeutics Corporation is based in FREEHOLD, N.J.

Key Statistics

Overview:

Market Capitalization, $K 3,978
Enterprise Value, $K 5,148
Shares Outstanding, K 6,028
Annual Sales, $ 0 K
Annual Net Income, $ -7,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,690 K
EBIT, $ -9,620 K
EBITDA, $ -9,430 K
% of Insider Shareholders 16.40%
% of Institutional Shareholders 77.96%
Float, K 5,039
% Float 83.60%
Short Volume Ratio 0.82

Growth:

1-Year Return -86.25%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/13/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -1.15
EPS Growth vs. Prev Qtr 6.45%
EPS Growth vs. Prev Year 212.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CHRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -453.90%
Profit Margin % 0.00%
Debt/Equity -1.60
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.25
Interest Coverage -13.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar